Omeros Announces Successful Primate Study in OncotoX-AML™ Drug Program

Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates ...

Four architectural requirements for unified fraud–AML detection by 2026

Fraud and anti-money laundering (AML) capabilities have advanced significantly in recent years. Yet in many institutions the two functions still operate on separate data, systems and incentives, ...
News Medical

Scientists develop mouse model to gain new insights into genetic mechanisms underlying AML

A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets. Scientists ...
Finextra

Securing weak spots in AML: Optimizing Model Evaluation with Automated Machine Learning

Manually evaluating transaction monitoring models is slow and error-prone, with mistakes resulting in potentially large fines. To avoid this, banks are increasingly turning to automated machine ...
Targeted Oncology

The Goldilocks Zone: New Study Clarifies CD25’s Role in High-Risk AML, ALL

CD25 expression has long been recognized as an adverse prognostic marker in acute leukemias including acute myeloid leukemia ...
GEN

Engineered Bone Marrow Model Advances CRISPR-CAR T Research in AML

Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...